Discover trends, market shifts, and competitive outlooks for the drug eluting stent industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Drug Eluting Stent Market Size Shifted, And What Is the Outlook Through 2034?

The size of the market for drug eluting stents has seen robust growth in the recent past. There is an expected escalation from $7.63 billion in 2024 to $8.29 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. Factors such as the demand for better treatment alternatives, clinical proof, regulatory sanction, health care economics, as well as guidelines and commendations, have contributed to the growth in the previous phase.

The market size of drug-eluting stent is predicted to experience significant growth in the forthcoming years, expanding to a substantial $11.37 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this projected growth in the forecast period include an increase in elderly population and chronic diseases, widening of indications, healthcare reimbursement policies, worldwide market expansion, and a focus on patient-centric care. The forecast period will also see key trends such as personalized medicine, minimally invasive procedures, emerging healthcare technologies, and advanced drug formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

What are the Fundamental Drivers and Innovations Shaping the Drug Eluting Stent Market?

The drug-eluting stent market’s growth is likely to be fueled by the escalating prevalence of coronary heart disease. This disease causes the coronary arteries to become narrowed or blocked due to the accumulation of plaque, potentially resulting in serious consequences such as heart attacks or chest pain. The rise in coronary heart disease is accredited to inactive lifestyles, unhealthy diets, aging demographics, and increased awareness. Drug-eluting stents (DES) can significantly alleviate coronary heart disease by efficiently unblocking or widening constricted coronary arteries and discharging drugs that hinder the artery from becoming narrow again (restenosis). The Centers for Disease Control and Prevention, an American governmental entity, reported in May 2024 that the prevalence of coronary heart disease in adults aged 18 and older in 2020 stood at 4.6%, surging to 4.9% in 2022. This surge in coronary heart disease is projected to stimulate the growth of the drug-eluting stent market.

How Is the Drug Eluting Stent Market Segmented?

The drug eluting stent market covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

Which Regions Are Driving the Next Phase of the Drug Eluting Stent Market Growth?

North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Drug Eluting Stent Industry?

Firms working in the drug-eluting stent market are concentrating on developing innovative delivery methods like the dual-layer balloon in order to enhance patient results and make strides in the area of interventional cardiology. The use of a dual-layer balloon in drug-eluting stent systems offers enhanced accuracy in drug delivery and stent deployment by granting better control and consistent drug application to the arterial wall. For example, in August 2022, Medtronic Plc, a healthcare solutions supplier based in Ireland, introduced Onyx Frontier, the most recent version of drug-eluting coronary stent systems designed to improve upon delivery systems and build on the acute performance and clinical data of the previous generation, Resolute Onyx DES. The Onyx Frontier DES utilizes the same leading-edge stent platform as the Resolute Onyx, catering to a wide size matrix to accommodate patients with diameters ranging from 2.0mm to 5.0mm. The Onyx Frontier DES includes noteworthy design enhancements, including an innovative dual-layer balloon, a minimized crossing profile, and enhanced catheter flexibility. These updates result in a 16% deliverability increase compared to the previous Resolute Onyx DES generation, without compromising radial strength.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

How Is the Drug Eluting Stent Market Defined and What Are Its Core Parameters?

A drug-eluting stent (DES) is a medical device used in the treatment of coronary artery disease (CAD). It is a small, mesh-like tube typically made of metal that is inserted into narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model